Emerging Nanotechnologies in Immunology. The Design, Applications and Toxicology of Nanopharmaceuticals and Nanovaccines. Micro and Nano Technologies

Table of Contents

1. Nanopharmaceutics in immunology: what's new in research? Ranjita Shegokar, Ana Rita Fernandes and Eliana Souto 2. Skin delivery of antimicrobial peptides Monika Schaefer-Korting and Jens Rolff 3. Skin penetration of nanoparticles Shohreh Nafisi and Howard I. Maibach 4. Regulatory and risk assessment perspective for Core-Multishell Nanocarriers: A novel excipient on its way towards marketing authorization Sam D. More, Margret More, Florian Paulus, Emanuel Fleige amd Marcin Libera 5. Anti-inflammatory drugs: Pharmaceutical Nanotechnology approach Andjelka B. Kovacevic, Sergio M.C.Silva and Slavomira Doktorovova 6. New strategies for the treatment of auto-immune diseases using nanotechnologies Amelia M. Silva, Joao R. Siopa, Carlos Martins-Gomes, Maria C. Teixeira, Dario J. Santos, Maria dos Anjos Pires and Tatiana Andreani 7. Nanopharmaceutics Applications in Inhaler Systems Aysu Yurdasiper, Mesut Arici and Mine Ozyazici 8. Immunomodulatory Effects of Curcumin in infectious and non-infectious diseases Ranjita Shegokar 9. Advances in Antibiotic Nanotherapy: Overcoming Antimicrobial Resistance Teixeira, M.C., Sanchez-Lopez, E., Espina, M., Calpena, A.C., Silva, A.M., Veiga, F.J., Garcia, M. L., Souto, E.B.

Authors

Ranjita Shegokar Capnomed GmbH, Tubingen, Germany. Dr. Ranjita Shegokar holds a PhD degree in Pharmaceutical Technology from the SNDT University, India, and has been postdoctoral researcher in the Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics at Free University of Berlin, Germany. Since last 8 years she is working in the pharmaceutical industry in various technical/R&D roles. Currently, she serves as Director of Pharma Business Unit at Capnomed GmbH, Germany. She has authored many research articles, book chapters, and presented several research papers in conferences. She has filed multiple patent application in area of drug delivery and drug targeting. She received several national and international awards for her research. Her areas of interest include polymeric nanoparticles, nanocrystals, lipid nanoparticles (SLNs/NLCs), nanoemulsions and role of excipients in delivery systems. Eliana B. Souto Department of Pharm. Technology, Faculty of Pharmacy, University of Porto, Porto, Portugal. Prof. Eliana Souto holds a Master's Degree in Pharmaceutical Technology and Pharmacotechnique from the Faculty of Pharmacy, University of Porto (2002), and the PhD in Pharmaceutical Technology, Biopharmaceutics and Biotechnology from the Institut für Pharmazie der Freie Universitaet Berlin, Germany (2005). Currently, she is affiliated with the Department of Pharmaceutical Technology of the Faculty of Pharmacy, University of Coimbra, and researcher at the Centre of Biological Engineering of University of Minho, Braga, both in Portugal. Since August 2012, Eliana holds the Habilitation Degree from the University Fernando Pessoa (Porto). Her major research lines focus on the design, and development of new drug delivery systems. Other research interests include the controlled delivery of drugs across biological barriers, with special emphasis for brain, ocular and skin administration. Eliana Souto is Associate Editor, member of the Editorial Board, and reviewer of several international scientific journals. She counts with 6 patents and more than 400 scientific publications in the field of Nanosciences and Nanotechnologies. Her h-index (Scopus) is 58.